Sanguina Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
2ndary - Private
- Investors
-
12
Sanguina General Information
Description
Provider of point-of-care diagnostics products designed to test hemoglobin levels. The company's products use color-based testing by emphasizing anemia screening, enabling users to test their hemoglobin levels in the blood and get the results back in a shorter period of time.
Contact Information
Website
www.sanguina.comCorporate Office
- 147 Technology Parkway
- Suite 100
- Peachtree Corners, GA 30092
- United States
Corporate Office
- 147 Technology Parkway
- Suite 100
- Peachtree Corners, GA 30092
- United States
Sanguina Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 15. Later Stage VC (Series A1) | 25-Jul-2023 | Completed | Generating Revenue | |||
| 14. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Grant | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series A) | 08-Dec-2020 | Completed | Generating Revenue | |||
| 10. Grant | 01-Sep-2019 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Grant | 01-Jan-2018 | $699K | $210K | Completed | Generating Revenue | |
| 7. Grant | 01-Jul-2015 | $225K | $210K | Completed | Generating Revenue |
Sanguina Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-5 | ||||||||
| Series A-3 | 2,026,017 | $0.000100 | $0.47 | $0.47 | 1x | $0.47 | 10.58% | |
| Series A-2 | 445,897 | $0.000100 | $0.21 | $0.21 | 1x | $0.21 | 2.33% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sanguina Comparisons
Industry
Financing
Details
Sanguina Competitors (1)
One of Sanguina’s competitors is Verv Technologies, a Venture Capital-Backed company based in Greater Sudbury, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verv Technologies | Venture Capital-Backed | Greater Sudbury, Canada |
Sanguina Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sanguina Patents
Sanguina Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12475558-B1 | Capillary refill image processing systems and processes | Active | 13-Mar-2023 | ||
| US-12268498-B2 | Systems and methods for quantitative diagnosis of anemia | Active | 05-Nov-2018 | ||
| US-12653428-B2 | Systems and methods for quantitative diagnosis of anemia | Active | 05-Nov-2018 | ||
| US-20210361195-A1 | Systems and methods for quantitative diagnosis of anemia | Active | 05-Nov-2018 | ||
| US-20250185953-A1 | Systems and methods for quantitative diagnosis of anemia | Active | 05-Nov-2018 | A61B5/1455 |
Sanguina Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sanguina Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cap-Meridian Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| GRA Venture Fund | Venture Capital | Minority | ||
| GTF Ventures | Venture Capital | Minority | ||
| Veritus Holdings | Holding Company | Minority |
Sanguina FAQs
-
When was Sanguina founded?
Sanguina was founded in 2012.
-
Where is Sanguina headquartered?
Sanguina is headquartered in Peachtree Corners, GA.
-
What is the size of Sanguina?
Sanguina has 17 total employees.
-
What industry is Sanguina in?
Sanguina’s primary industry is Diagnostic Equipment.
-
Is Sanguina a private or public company?
Sanguina is a Private company.
-
What is Sanguina’s current revenue?
The current revenue for Sanguina is .
-
How much funding has Sanguina raised over time?
Sanguina has raised $6M.
-
Who are Sanguina’s investors?
Cap-Meridian Ventures, , GRA Venture Fund, GTF Ventures, and Veritus Holdings are 5 of 12 investors who have invested in Sanguina.
-
Who are Sanguina’s competitors?
Verv Technologies is a competitor of Sanguina.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
